BMI1 and melanoma: In a study of melanoma (Liu et al., 2012), a knockdown of a polycomb group protein (BMI1) expression in these tumor cells resulted in higher chemo sensitivity of these cells toward cisplatin together with a presence of reduced ATP-binding-cassette (ABC) transporters, which are the transporters of various substance in the cells.